- Home
- LVTX vs SXTC Comparison
LVTX vs SXTC Comparison
Compare LVTX & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVTX
- SXTC
- Stock Information
- Founded
- LVTX 2016
- SXTC 2005
- Country
- LVTX Netherlands
- SXTC China
- Employees
- LVTX N/A
- SXTC N/A
- Industry
- LVTX Biotechnology: Pharmaceutical Preparations
- SXTC Biotechnology: Pharmaceutical Preparations
- Sector
- LVTX Health Care
- SXTC Health Care
- Exchange
- LVTX Nasdaq
- SXTC Nasdaq
- Market Cap
- LVTX 33.9M
- SXTC 34.4M
- IPO Year
- LVTX 2021
- SXTC 2019
- Fundamental
- Price
- LVTX $1.31
- SXTC $1.85
- Analyst Decision
- LVTX Hold
- SXTC
- Analyst Count
- LVTX 3
- SXTC 0
- Target Price
- LVTX $1.75
- SXTC N/A
- AVG Volume (30 Days)
- LVTX 39.1K
- SXTC 726.7K
- Earning Date
- LVTX 08-19-2025
- SXTC 01-01-0001
- Dividend Yield
- LVTX N/A
- SXTC N/A
- EPS Growth
- LVTX N/A
- SXTC N/A
- EPS
- LVTX N/A
- SXTC 20.77
- Revenue
- LVTX $4,990,000.00
- SXTC $1,818,404.00
- Revenue This Year
- LVTX N/A
- SXTC N/A
- Revenue Next Year
- LVTX N/A
- SXTC N/A
- P/E Ratio
- LVTX N/A
- SXTC $0.09
- Revenue Growth
- LVTX N/A
- SXTC 6.78
- 52 Week Low
- LVTX $0.85
- SXTC $0.95
- 52 Week High
- LVTX $2.39
- SXTC $11.92
- Technical
- Relative Strength Index (RSI)
- LVTX 51.02
- SXTC 51.80
- Support Level
- LVTX $1.28
- SXTC $1.84
- Resistance Level
- LVTX $1.40
- SXTC $1.95
- Average True Range (ATR)
- LVTX 0.05
- SXTC 0.29
- MACD
- LVTX -0.00
- SXTC 0.04
- Stochastic Oscillator
- LVTX 52.63
- SXTC 62.50
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.